OTCMKTS:CRXM Gene Biotherapeutics (CRXM) Stock Price, News & Analysis → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free CRXM Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume10 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get Gene Biotherapeutics alerts: Email Address Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Gene Biotherapeutics Stock (OTCMKTS:CRXM)Gene Biotherapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of angiogenic gene therapy biotherapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product candidate is Generx, an angiogenic gene therapy product candidate in Phase 3 clinical trials for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease. It is also developing Generx for ischemia-related cardiovascular and cerebral therapeutic indications. Gene Biotherapeutics, Inc. has an agreement with Fujifilm Diosynth Biotechnologies for the manufacture of Generx angiogenic gene therapy product for Phase 3 clinical evaluation. The company was formerly known as Taxus Cardium Pharmaceuticals Group, Inc. and changed its name to Gene Biotherapeutics, Inc. in January 2018. Gene Biotherapeutics, Inc. was incorporated in 2003 and is headquartered in San Diego, California.Read More Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. CRXM Stock News HeadlinesMay 7, 2024 | msn.comNorth Gene Autry reopens in Palm Springs as Indian Canyon still closed; more wind expectedMay 7, 2024 | msn.comAmerica’s Greatest Detective Finalist: Gene and Sandy RalstonMay 8, 2024 | Crypto 101 Media (Ad)Tech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. May 7, 2024 | uk.finance.yahoo.comGene Editing Collaboration, R&D, and Licensing Deals Analysis Report 2024 with Directory of 354 Agreements Signed Since 2016May 6, 2024 | usnews.comPeople With Two Copies of a Risk Gene Have Genetic Form of Alzheimer's, Scientists SayMay 6, 2024 | finance.yahoo.comBioIVT Highlights its Focus on Cell and Gene Therapy in Spring Industry EventsMay 5, 2024 | msn.comXboxEra Podcast Episode 210 | "Redacted featuring Gene Park"May 4, 2024 | msn.comThe Two Forgotten Gene Roddenberry Shows Star Trek Fans Need To WatchMay 8, 2024 | Crypto 101 Media (Ad)Tech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. May 4, 2024 | msn.com10 Best Gene Tierney Movies RankedMay 4, 2024 | msn.comGene Wilder Insisted That His Acrobatic Grand Entrance Be Included in ‘Willy Wonka and the Chocolate Factory'May 3, 2024 | msn.com‘We came from the most humble beginnings,’ Shocker baseball legend Gene Stephenson explains the reason behind his $600,000 donationMay 2, 2024 | msn.comGene Stephenson donates to Wichita State baseballMay 2, 2024 | finance.yahoo.comFounder & CEO of Lead Ninja System, Gene Slade, is Proud to Announce He Will Speak at Rocket X Event May 1st - 3rd 2024April 30, 2024 | markets.businessinsider.com11 Analysts Assess Taysha Gene Therapies: What You Need To KnowApril 30, 2024 | msn.comIndian Canyon Drive, Gene Autry Trail reopen in Palm SpringsApril 29, 2024 | msn.comMotorcyclist dies in crash on Gene Autry Trail in Palm SpringsApril 29, 2024 | finance.yahoo.comNanoscope Therapeutics to Present at the OIS and Retinal Cell and Gene Therapy Innovation SummitsApril 28, 2024 | msn.comGene Frenette: Jaguars, Baalke loading up on SEC talent to try and get their groove backApril 26, 2024 | bizjournals.comAdvocate Health CEO Gene Woods offers answers for high costs of health careApril 25, 2024 | finance.yahoo.comGene Therapy For Ocular Rare Disease Pipeline Insight Report 2024April 24, 2024 | msn.comOmaha Police increase presence at Gene Leahy MallApril 24, 2024 | msn.comWatch Gene Simmons Ditch the Makeup and Play First Concert Since KISS Farewell ShowApril 23, 2024 | usatoday.comFormer Purdue basketball coach Gene Keady to be inducted into NJCAA Hall of FameApril 23, 2024 | msn.com‘American Idol’ recap: Gene Simmons’ advice to Alabama’s Triston Harper, Mia MatthewsApril 23, 2024 | finance.yahoo.comFirst Clinical Trial Results of Gene Therapy (GNT0004) for Duchenne Muscular Dystrophy Presented at International Myology 2024 CongressApril 23, 2024 | finance.yahoo.comSania Therapeutics presents latest from AAV gene therapy platform at the American Society of Gene & Cell Therapy Annual MeetingSee More Headlines Receive CRXM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Gene Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolOTCMKTS:CRXM Previous SymbolNYSE:CXM CUSIPN/A CIK772320 Webwww.cardiumthx.com Phone(858) 414-1477Fax858-436-1001Employees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Christopher J. Reinhard (Age 70)Co-Founder, CEO, President, Treasurer & Director Comp: $240kMr. James L. Grainer (Age 69)Chairman, CFO & Secretary Dr. Lois A. Chandler (Age 66)Chief Operating Officer Dr. Ronald J. Shebuski (Age 71)Chief Scientific Officer Mr. Duane LinstromGeneral CounselKey CompetitorsAdvanced Life SciencesOTCMKTS:ADLSAlvotechNYSE:ALVOAVAX TechnologiesOTCMKTS:AVXTEnzon PharmaceuticalsOTCMKTS:ENZNGenocea BiosciencesNASDAQ:GNCAQView All Competitors CRXM Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Gene Biotherapeutics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Gene Biotherapeutics investors own include Brainstorm Cell Therapeutics (BCLI), Organovo (ONVO), Anavex Life Sciences (AVXL), Sangamo Therapeutics (SGMO), Adaptimmune Therapeutics (ADAP), Intellipharmaceutics International (IPCIF), MGT Capital Investments (MGTI) and Nokia Oyj (NOK). How do I buy shares of Gene Biotherapeutics? Shares of CRXM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CRXM) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressGold Set to EXPLODE!Gold Safe ExchangeThe AI Stock that’s Disrupting Every IndustryStockEarningsThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gene Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.